Navamedic ASA launches Modifast in Norway
Oslo, 30 January 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces it has launched Modifast, a range of low calorie diet (LCD) meal replacement products, in the Norwegian market. Modifast is part of Navamedic’s growing portfolio of products and solutions aimed at tackling obesity and consists of supplements, prescription medications, diet replacements and online patient support portals.“The experience from Sweden shows that Modifast and obesity related products are highly suited for online